Literature DB >> 7350174

Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease.

G A Burghen, J R Givens, A E Kitabchi.   

Abstract

We evaluated basal plasma total immunoreactive insulin (insulin), androstenedione, and testosterone in 14 obese women: 8 with polycystic ovarian disease (PCOD) and 6 obese controls. All 3 hormones were significantly elevated (P less than 0.02 to P less than 0.001) in PCOD patients. A significant correlation among basal levels of plasma insulin, androstenedione, and testosterone was demonstrated. The PCOD group had significantly higher levels of glucose at 1, 2, and 3 h, with similar significant increases in plasma insulin levels at 0, 2, and 3 h. A significant correlation was found between plasma insulin response areas and plasma testosterone (P less than 0.001) in the control and PCOD patients. These studies demonstrate that hyperandrogenism correlates with hyperinsulinism.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7350174     DOI: 10.1210/jcem-50-1-113

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  128 in total

Review 1.  The ovarian androgen-producing cells: a 2001 perspective.

Authors:  Denis A Magoffin
Journal:  Rev Endocr Metab Disord       Date:  2002-01       Impact factor: 6.514

2.  Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome.

Authors:  Susan Sam; David A Ehrmann
Journal:  Diabetologia       Date:  2017-08-03       Impact factor: 10.122

Review 3.  Fertility treatment in women with polycystic ovary syndrome: a decision analysis of different oral ovulation induction agents.

Authors:  Emily S Jungheim; Anthony O Odibo
Journal:  Fertil Steril       Date:  2010-05-07       Impact factor: 7.329

Review 4.  Hirsutism: pilosebaceous unit dysregulation. Role of peripheral and glandular factors.

Authors:  V Toscano
Journal:  J Endocrinol Invest       Date:  1991-02       Impact factor: 4.256

Review 5.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

6.  Heat therapy improves glucose tolerance and adipose tissue insulin signaling in polycystic ovary syndrome.

Authors:  Brett R Ely; Zachary S Clayton; Carrie E McCurdy; Joshua Pfeiffer; Karen Wiedenfeld Needham; Lindan N Comrada; Christopher T Minson
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-05-28       Impact factor: 4.310

7.  The relationships between testosterone, body composition, and insulin resistance: a lesson from a case of extreme hyperandrogenism.

Authors:  Elena Volpi; Steven A Lieberman; Dennis M Ferrer; Charles R Gilkison; Blake B Rasmussen; Manubai Nagamani; Randall J Urban
Journal:  Diabetes Care       Date:  2005-02       Impact factor: 19.112

8.  Is hyperprolactinemia associated with insulin resistance in non-obese patients with polycystic ovary syndrome?

Authors:  M Bahceci; A Tuzcu; S Bahceci; S Tuzcu
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

Review 9.  Obesity and PCOS: the effect of metabolic derangements on endometrial receptivity at the time of implantation.

Authors:  Maureen M B Schulte; Jui-he Tsai; Kelle H Moley
Journal:  Reprod Sci       Date:  2014-12-07       Impact factor: 3.060

10.  The efficacy of metformin in pregnant women with polycystic ovary syndrome: a meta-analysis of clinical trials.

Authors:  J Zheng; P F Shan; W Gu
Journal:  J Endocrinol Invest       Date:  2013-04-12       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.